BI-0474 | m-entrepreneurship.com

Product Name :
BI-0474

Search keywords :
BI-0474

drugId :
null

Target Vo:
KRAS G12C

Target Vo Short Name :
KRAS G12C

Moa_Name:
KRAS G12C inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Boehringer Ingelheim Rcv Gmbh & Co. Kg

Active Company_Name :
Boehringer Ingelheim Rcv Gmbh & Co. Kg

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cytochrome C Rabbit mAb Biological Activity
p27 KIP 1 Rabbit mAb Data Sheet
xCT Antibody (YA006): xCT Antibody (YA006) is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to xCT. It can be used for WB,IP assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts